FDA Approves Upadacitinib for Ulcerative Colitis FDA Approves Upadacitinib for Ulcerative Colitis

Upadacitinib has been shown to rapidly control symptoms in adults with moderate to severe active ulcerative colitis. It ’s the first FDA approval for the JAK inhibitor in gastroenterology.FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news